The overall aim of the Metabolic Disease Research Unit (MDRU) is to advance translational research in the pathophysiology, diagnosis and treatment of metabolic disorders such as obesity, type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). Through a multidisciplinary approach combining fundamental research, molecular biology, biochemistry, multi-omics and data science, the MDRU will foster innovation and collaboration to improve metabolic health. The functioning of MDRU is based on the complementary field of research and expertise of different departments of IBISS in the metabolic disease research, and includes shared facilities, infrastructure and technology.
The main mission of MDRU is support the collaboration of research groups with different scientific backgrounds and the training of young researchers and innovators in translational research in the field of metabolic diseases.
Main objectives:
• Improvement of basic and translational metabolic disease research
• Implementation of a research roadmap based on multi-omics and bioinformatics
• Accelerated discovery of new disease biomarker and therapeutic targets
• Enhanced outreach activities and awareness from metabolic diseases in the general population
Coordinator: Dr. Nataša Veličković, Department of Biochemistry
Participating departments:
1. Department of Biochemistry
2. Department of Molecular Biology
3. Department of Immunology
4. Department of Plant Physiology
5. Department of Cytology
6. Department of Neurobiology
7. Department of Neurophysiology
8. Department of Ecology
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.